The relationship between carbohydrate intake and glucose tolerance in pregnant women
|
|
- Mervin Hawkins
- 5 years ago
- Views:
Transcription
1 Acta Obstet Gynecol Scand 2003: 82: Copyright # Acta Obstet Gynecol Scand 2003 Printed in Denmark. All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN ORIGINAL ARTICLE The relationship between carbohydrate intake and glucose tolerance in pregnant women MOTOI TAKIZAWA 1,TAKASHI KANEKO 2,KEIKO KOHNO 1,YUKIHITO FUKADA 1 AND KAZUHIKO HOSHI 1 From the Departments of 1 Obstetrics and Gynecology and 2 Environmental Health, Yamanashi Medical University, Yamanashi, Japan Acta Obstet Gynecol Scand 2003; 82: # Acta Obstet Gynecol Scand Objective. We verified whether a misdiagnosis of gestational diabetes mellitus can result in pregnant women when glucose tolerance has deteriorated after a low-carbohydrate meal, and tried to elucidate the mechanism behind the different outcome of the test. Study design. Twenty-seven pregnant women were given directions for their evening meal the day before each of two 75-g oral glucose tolerance tests (OGTT). The evening meal was either a low-carbohydrate meal (carbohydrate, 6.7%; Low), or a high-carbohydrate meal (carbohydrate, 85.7%; High). Results. The OGTT showed that the glucose tolerance was significantly impaired after Low than after High, with a significant increase of fasting plasma non-esterified fatty acids (NEFA) level. Moreover, the insulinogenic index (I-I) after High significantly decreased than that after Low. Conclusions. The present data suggests that there is a risk of misdiagnosis of impaired glucose tolerance with only one intake of this extremely low-carbohydrate meal on the evening before testing. The decrease of insulin secretion and the activation of glucose-fatty acid cycle may be considered as the mechanism. Key words: 75-g oral glucose tolerance test; carbohydrate intake; gestational diabetes mellitus; glucose-fatty acid (Randle) cycle; insulinogenic index Submitted 29 July, 2002 Accepted 27 January, 2003 It is well known that glucose tolerance deteriorates during pregnancy. This impairment of glucose tolerance with pregnancy is called gestational diabetes mellitus (GDM), an intriguing pathological state that shows specificity for glucose metabolism in pregnant women. The incidence rate of GDM in Japan is reported to be about % (1). In Abbreviations: GDM: gestational diabetes mellitus; DM: diabetes mellitus; OGTT: oral glucose tolerance test; GCT: glucose challenge test; NEFA: non-esterified fatty acids; BMI: body mass index; g-auc: area under the plasma glucose concentration-time curve; Low: low-carbohydrate meal; High: high-carbohydrate meal;. HOMA: homeostasis model assessment; I-I: insulinogenic index. general, the impairment of glucose tolerance is less severe than that in pregnant women with comorbid diabetes mellitus (DM), but because of the risk of fetal and neonatal abnormalities [e.g. fetal and neonatal death, fetal macrosomia (1), and respiratory distress syndrome], similar to those for pregnant women with DM, early measures are essential for the diagnosis of GDM in the clinical setting. Additionally, given the high probability of future progression to DM for women with GDM, great importance is also attached to early diagnosis from the perspective of predicting the development of DM. The diagnostic technique that is widely used in the field of obstetrics is the oral glucose tolerance
2 Carbohydrate intake and glucose tolerance 1081 test (OGTT). The American Diabetes Association recommends the following procedure: screen pregnant women with a 50-g glucose challenge test (GCT) at weeks of gestation, and select those whose plasma glucose level at 60 min after loading exceeds 140 mg/dl (¼7.7 mmol/l) (2). Make a definitive diagnosis for patients yielding a positive result with a 100-g OGTT. The Japan Society of Obstetrics and Gynecology also recommends the 50-g GCT as a screening method, and the 75-g OGTT to confirm the diagnosis in patients producing a positive result at screening (3,4). Because patients are typically directed to fast from 21:00 hours the evening before the day of the OGTT, they tend to make do with a light evening meal on the day before the test (for example, a garden salad). However, it is important to ensure a sufficient carbohydrate intake from the evening meal the day before the test. If not, the test results may be assessed as indicating diabetes or impaired glucose tolerance (5). It has also been reported that the plasma concentration of non-esterified fatty acids (NEFA) specifically increases after low-carbohydrate meals (6). In the present work, we sought to verify whether a misdiagnosis of GDM can result in pregnant women when glucose tolerance has deteriorated after a low-carbohydrate meal, and tried to elucidate the mechanism behind the different outcome of the test. Materials and methods Subjects We recruited the volunteers from the pregnant women at weeks of gestation who visited the Department of Obstetrics and Gynecology of Yamanashi Medical University as outpatients from 1999 to The subjects for the tests were sampled from among pregnant women in whom DM was not identified as a complication before pregnancy. The objectives of the research were fully explained to 27 Japanese pregnant women [age, years; body mass index (BMI), kg/m 2 : given in means SD] who gave their consent to participate in the study. They were given directions for their evening meal the day before each of two 75-g OGTT. The tests were performed 5 14 days apart. The present study was approved by the university ethics committee. Diet description and 75-g oral glucose tolerance test After their usual meals at breakfast and lunchtime on the day before testing, subjects were directed to adhere rigorously to a prescribed menu for the evening meal, ensuring they ate between 18:30 and 20:00 hours. Calorific intake was forbidden from 22:00 hours onwards. On the day of testing, a 75-g OGTT was performed from 09:00 hours. First, fasting blood samples were withdrawn (before glucose loading), then subjects were given a drink containing 75 g of carbohydrate to be taken over a period of 5 min. Venous blood samples were then successively withdrawn at 30, 60 and 120 min for measurements of plasma glucose levels. The concentrations of insulin and c-peptide in serum were measured before loading, and at 30 and 120 min. The plasma concentrations of triglycerides (TG) and NEFA were measured in preloading blood samples. Glucose tolerance was evaluated according to WHO categories: normal, impaired glucose tolerance, or diabetic (7). The area under the plasma glucose concentration-time curve (g-auc) was determined by the trapezoidal rule. The insulinogenic index (I-I) (increment in serum insulin concentration for 30 min/increment in plasma glucose concentration for 30 min after loading) was calculated to evaluate the insulin secretion response (8). The homeostasis model assessment (HOMA) index was used as an indicator of insulin sensitivity (9). The evening meal was either a lowcarbohydrate meal of 505 kcal, of which the carbohydrate content was 6.7% (Low), or a high-carbohydrate meal of 518 kcal, of which the carbohydrate content was 85.7% (High). On the day of the test, the investigator confirmed that the test meal had been eaten. All subjects ate the meals as directed. Throughout the testing period, vigorous exercise was restricted. No subjects complained of poor physical condition during the testing period. Subjects were randomized to either the low-carbohydrate meal on the day before the first test then the high-carbohydrate meal on the day before the second test (Low/ High), or vice versa (High/Low). Briefly, in accordance with a randomized cross-over design, 13 subjects were assigned to the Low/High testing sequence and 14 to the High/Low sequence. There were no differences between the Low/ High group and High/Low group with respect to the characteristics of age, parity, BMI, gestational weeks of first test, or interval between testing (Table I). Statistical analysis Data were presented as means SD for 27 subjects, and the data were statistically analyzed by two-way ANOVA with a computer software
3 1082 T. Kaneko et al. Table I. Characteristics of subjects Number of patients Age (years) Parity (times) BMI (kg/m 2 ) Gestational weeks of 1st test Interval days between testing Overall Low/High High/Low Plus/minus values are means SD. (StatView 5.0, Abacus Co., Berkeley, California, USA), and between-group comparisons were performed using Student s paired t-test. Differences were regarded as significant when the p-level was below Results The results obtained from 75-g OGTT after highcarbohydrate (High) and low-carbohydrate evening meals (Low) the day before testing are presented below. Before glucose loading, the mean plasma glucose concentration was mmol/l after the High meal and mmol/l after the Low meal. At 60 min, the concentration was mmol/l after the High meal and mmol/l after the Low meal. At 120 min, the concentration was mmol/l after the High meal and mmol/l after the Low meal. The paired t-test was used to analyze plasma glucose levels before and at 60 and 120 min after glucose loading. Before loading, the plasma glucose level after the Low meal was significantly lower than the corresponding level after the High meal. At 60 min after loading, the plasma glucose level after the Low meal was significantly higher than that after the High meal. At 120 min after loading, the plasma glucose level after the Low meal was significantly higher than that after the High meal (Fig. 1). Data on the mean serum insulin concentration before loading and mean serum insulin concentration at 30 min are shown in Table II. Statistical analysis of the serum insulin levels measured after the High meal and after the Low meal disclosed no significant differences between the values before loading or at 30 min (before loading, p ¼ 0.050; 30 min, p ¼ 0.079). Plasma glucose * High CH Low CH ** Before 60 (time, min) ** 120 * p < 0.05 ** p < 0.01 Fig. 1. Plasma glucose responses after different evening meals (a high-carbohydrate meal, High CH and a low-carbohydrate meal, Low CH) on the day before the 75-g oral glucose tolerance test (OGTT). Table II. Plasma glucose and serum insulin levels before and at 30 min after glucose loading, insulinogenic index, fasting plasma non-esterified fatty acids levels, and homeostasis model assessment index, after high-carbohydrate (High CH) or low-carbohydrate meals (Low CH) Glucose before 30 min Insulin before 30 min (pmol/l) I-I (pmol/mmol) NEFA (meq/l) HOMA High CH Low CH * NS * NS NS I-I: insulinogenic index; NEFA: non-esterified fatty acid; HOMA: homeostasis model assessment. NS: not significant. *p < 0.05; p < Plus/minus values are means SD.
4 Carbohydrate intake and glucose tolerance 1083 Investigation of the HOMA index disclosed no significant differences between the two groups (p ¼ 0.730). We also investigated the mean serum insulin concentration and change in insulin concentration relative to the change in plasma glucose level at 30 min, i.e. I-I. The mean I-I was 146 after the High meal, significantly different from the figure of 58.8 after the Low meal. In brief, these data suggested that the insulin secretion response to the increased plasma glucose level was lower after the Low meal than after the High meal. To evaluate the causal factors behind the meal effects, we also measured the plasma concentrations of TG and NEFA before glucose loading. The TG concentrations were not significantly different between the two groups. On the other hand, the NEFA concentration after the High meal was significantly lower than that after the Low meal (Tables II and III). In 5 of the 27 subjects tested, the OGTT findings were in concordance with the diagnostic criteria for GDM (Japan Society of Obstetrics and Gynecology) after the Low meal, but lay outside the diagnostic limits after the High meal (Fig. 2). To analyze any potential difference in findings due to increased duration of pregnancy between the first and second OGTT, we also stratified the results for the individual meal sequences (Table III). The fact that plasma glucose levels were low before loading and increased after loading in the Low group, and that I-I and NEFA concentrations in the Low group were lower than those in the High group, indicated that reversing the sequence of low- and high-carbohydrate meals had no effect on outcome. Discussion In research in which predetermined meals were fed to healthy young males for 7 days, Himsworth concluded that the only dietary factor that determined glucose tolerance and insulin sensitivity in healthy individuals was carbohydrate intake, and that carbohydrate intake ratio, lipid intake and lipid intake ratio had no effect (10 12). Furthermore, since Wilkerson et al. reported the absence of a significant relationship between carbohydrate intake and glucose tolerance in healthy adults (13), the importance of carbohydrate intake the day before glucose tolerance testing has not been greatly emphasized. To shed further light on this question, Kaneko et al. re-evaluated the association between carbohydrate intake the day before OGTT and glucose tolerance in healthy adult volunteers (5,6). They found that all subjects in the high-carbohydrate diet group exhibited normal glucose tolerance, but those in the low-carbohydrate diet group had significantly worse glucose tolerance. g-auc in the low-carbohydrate diet group was significantly higher and the I-I was significantly lower than that in the high-carbohydrate diet group. Furthermore, the fasting plasma concentration of NEFA in the low-carbohydrate diet group was significantly higher. These findings led to the suggestion that the deterioration in glucose tolerance due to lowcarbohydrate intake may have been caused by decreased insulin secretion (I-I) and activation of the Randle (glucose-fatty acid) cycle. The fact that there was also a significant correlation between fasting plasma NEFA concentration and g-auc suggested that the increase in fasting plasma NEFA concentration might serve as an indicator for predicting deterioration in glucose Table III. OGTT findings; plasma glucose levels before and at 60 and 120 min after glucose loading, insulinogenic index (I-I), and fasting plasma non-esterified fatty acids levels (NEFA) Low/High sequence Low/High (13 subjects) Before 60 min 120 min I-I (pmol/mmol) NEFA (meq/l) High Low p-value High/Low sequence High/Low (14 subjects) Before 60 min 120 min I-I (pmol/mmol) NEFA (meq/l) High Low p-value Plus/minus values are means SD.
5 1084 T. Kaneko et al. Fig. 2. Five subjects whose 75-g oral glucose tolerance test (OGTT) findings were outside the diagnostic criteria of gestational diabetes mellitus (GDM) after a high-carbohydrate meal (High CH), despite conforming to the diagnostic criteria of GDM after a low-carbohydrate meal (Low CH). tolerance. This finding led to the hypothesis that persons who eat a low-carbohydrate meal before undergoing OGTT might be misdiagnosed with impaired glucose tolerance (5,6). The most significant change caused by intake of a low-carbohydrate meal is the increase in fasting plasma NEFA concentration. Randle et al. discovered the existence of a link between carbohydrate and lipid metabolism, naming it the Randle cycle (14,15), which has become a new focus of worldwide attention. The findings of our research can also be explained by these hypotheses. Many testing centers encourage the intake of meals containing at least 150 g/day of carbohydrates for 3 days before OGTT, because they believe that such preparatory meals will reduce false GDM positivity. Some researchers claim that restrictions on carbohydrate intake are not required to address this problem. In a prospective study, Salmon et al. found no significant differences with respect to mean plasma glucose concentration between groups of patients that ate preparatory meals and those that did not, with no differences seen in the number of subjects with OGTT abnormalities (16). They concluded that dietary prescriptions would unnecessarily delay the diagnosis of GDM, given that the OGTT findings were not significantly altered in healthy pregnant women. Major et al. investigated the effects of restrictions on carbohydrate intake (one group with a carbohydrate content of less than 42% and the other with a content greater than 45%) on perinatal prognosis for GDM patients receiving dietary therapy (17). They found that restricting carbohydrate intake in GDM patients led to improved control of plasma glucose. They also reported that the number of indications for insulin therapy diminished, and that the incidence rate of large for gestational age, and cesarean sections due to cephalopelvic disproportion or fetal macrosomia were reduced. Peterson et al. conducted a cross-over study of dietary content (carbohydrate ratio) and metabolic response in obese women whose body weight had been reduced by diet therapy, and found that low-carbohydrate, high-fat diet therapy produces an excellent lipid profile in obese women (18). At the same time, these researchers also investigated the effects of a past history of GDM. Their results suggest that maximum OGTT values, fasting insulin levels and insulin resistance are higher in obese women with a history of GDM, compared with findings for obese women without such a history. Entrekin et al. investigated the effects of high-carbohydrate preparatory meals on 3-h OGTT in pregnant women (19). In an investigation of pregnant women with abnormal findings on plasma glucose screening tests, they analyzed the subjects in three groups, according to the carbohydrate content of meals eaten before testing. Given that the clinical outcomes were the same for fasting plasma glucose, and the 1, 2, and 3-h levels in the three groups, it was concluded that high-carbohydrate meals had no greater effects than normal meals in pregnant women undergoing OGTT. In all the above reports in which it was concluded that there is no need to restrict carbohydrate intake, the carbohydrate content of the meals was about 40 50%. The low-carbohydrate meal used in the present study was 10% carbohydrate. The present data suggests that there is a risk of misdiagnosis of impaired glucose tolerance with only one intake of this extremely lowcarbohydrate meal on the evening before testing.
6 Carbohydrate intake and glucose tolerance 1085 The present finding in women with normal OGTT is applied to women in the lower range of glucose intolerance, which was demonstrated in an additional experiment (data not shown, personal communication). References 1. Sato K, Fujimoto S. [Evidence-Based Medicine.] (in Japanese). In: Sato K, Fujimoto S (eds). Tokyo: Medical View Corporation, 1999: Stephen R, Carr MD. Screenig for gestational diabetes mellitus. Diabetes Care 1988; 21: B Japan Society of Obstetrics and Gynecology, Subcommittee to diagnose or control the gestational diabetes mellitus in Japan. [Report by a committee of nutrition and metabolism: a suggestion to control the gestational diabetes mellitus and the pregnancy with diabetes mellitus.] (in Japanese with an English Abstract) Acta Obstet Gynaecol Jpn 1985; 37: Japan Society of Obstetrics and Gynecology, A committee of the perinatal medicine in Japan. [A report about the gestational diabetes mellitus (GDM).] (in Japanese with an English Abstract) Acta Obstet Gynaecol Jpn 1995; 47: Kaneko T, Wang P-Y, Tawata M, Sato A. Low carbohydrate intake before oral glucose-tolerance tests. [Res Letter] Lancet 1998; 352: Wang P-Y, Kaneko T, Wang Y, Tawata M, Sato A. A low carbohydrate intake before an oral glucose tolerance test impairs the glucose tolerance of normal adults. Tohoku J Exp Med 1999; 189: Alberti KGMM. The diagnosis and classification of diabetes mellitus. Diabetes Voice 1999; 44: Seltzer HS, Allen EW, Herton AL, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967; 46: Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: Himsworth HP. Dietetic factor determining glucose tolerance and sensitivity to insulin of healthy men. Clin Sci 1935; 2: Himsworth HP, Marshall EM. The diet of diabetics prior to the onset of the disease. Clin Sci 1935; 2: Himsworth HP. Diet and the incidence of diabetes. Clin Sci 1935; 2: Wilkerson HLC, Hyman H, Kaufman M, McCuistion AC, Francis JO S. Diagnostic evaluation of oral glucose tolerance tests in nondiabetic subjects after various levels of carbohydrate intake. N Engl J Med 1960; 262: Randle PJ, Garland PB, Hales CN, Newsholm EA. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; I: Sugden MC, Sharples SC, Randle PJ. Carcass glycogen as a potential source of glucose during short-term starvation. Biochem J 1976; 160: Salmon MC. Oral glucose tolerance test and preparatory diet. Am J Obstet Gynaecol 2000; 182: Major CA, Henry MJ, DeVeciana M, Morgan MA. The effect of carbohydrate restriction in patients with dietcontrolled gestational diabetes. Obstet Gynaecol 1998; 91: Peterson CM, Jovanovic-Peterson L. Randomized crossover study of 40% vs. 55% carbohydrate weight loss strategies in women with previous gestational diabetes mellitus and non-diabetic women of % ideal body weight. J Am Coll Nutr 1995; 14: Entrekin K, Work B, Owen J. Does a high carbohydrate preparatory diet affect the 3-hour oral glucose tolerance test in pregnancy? J Maternal-Fetal Med 1998; 7: Address for correspondence: Takashi Kaneko Department of Environmental Health Yamanashi Medical University Shimokato 1110 Tamaho Yamanashi Japan tkaneko@y-eisei
Original Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1)
Yamanashi Med. J. 21(3), 53 ~ 58, 2006 Original Article Usefulness of the 50-g Glucose Challenge Test for Screening of Patients with Gestational Diabetes Mellitus and an Analysis of the Timing of Administration
More informationClinical Study 1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women
Hindawi Publishing Corporation International Journal of Endocrinology Volume 2012, Article ID 460509, 5 pages doi:10.1155/2012/460509 Clinical Study 1-Hour OGTT Plasma Glucose as a Marker of Progressive
More informationPregnancy complications and glucose intolerance in women with polycystic ovary syndrome
Endocrine Journal 2015, 62 (11), 1017-1023 Original Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome Mari Sawada, Hisashi Masuyama, Kei Hayata, Yasuhiko Kamada, Keiichiro
More informationDiagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria
Asian Biomedicine Vol. 8 No. 4 August 2014; 505-509 Brief communication (Original) DOI: 10.5372/1905-7415.0804.320 Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationA CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V.
A CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V. Baby Paul 3 HOW TO CITE THIS ARTICLE: Baiju Sam Jacob, Girija Devi K, V. Baby Paul.
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationCurrent Trends in Diagnosis and Management of Gestational Diabetes
Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives
More informationAssociations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes
ORIGINAL ARTICLE korean j intern med 2012;27:66-71 pissn 1226-3303 eissn 2005-6648 Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset
More informationScreening and Diagnosis of Diabetes Mellitus in Taiwan
Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationEffect of a low-glycemic-index diet during pregnancy on obstetric outcomes 1 3
Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes 1 3 Robert G Moses, Megan Luebcke, Warren S Davis, Keith J Coleman, Linda C Tapsell, Peter Petocz, and Jennie C Brand-Miller ABSTRACT
More informationInfluence of Abnormal GCT with Normal or Impaired OGTT on Neonatal Outcome
JMSCR Volume 2 Issue 9 Page 2471-2482 September-2014 2014 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Influence of Abnormal GCT with Normal or Impaired OGTT on Neonatal Outcome Authors
More informationA Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 2586-2590 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.304
More informationEstimates of Insulin Sensitivity Using Glucose and C-Peptide From the Hyperglycemia and Adverse Pregnancy Outcome Glucose Tolerance Test
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Estimates of Insulin Sensitivity Using Glucose and C-Peptide From the Hyperglycemia and Adverse Pregnancy Outcome Glucose
More informationMaximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE
Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationSubsequent Pregnancy After Gestational Diabetes Mellitus. Frequency and risk factors for recurrence in Korean women
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Subsequent Pregnancy After Gestational Diabetes Mellitus Frequency and risk factors for recurrence in Korean women SOO HEON KWAK, MD 1 HAE
More informationGestational Diabetes in Rural Antenatal Clinics:
Gestational Diabetes in Rural Antenatal Clinics: How do we compare? Cook SJ 1,2, Phelps L 1, Kwan M 2 Darling Downs Health and Hospital Service University of Queensland Rural Clinical School Gestational
More informationAPEC Guidelines Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is defined as insulin resistance of variable severity with onset or first recognition during pregnancy. The prevalence of diabetes mellitus (DM) in the US is growing
More information2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
More informationGestational Diabetes Mellitus
Gestational Diabetes Mellitus Should GPs keep a register of everyone with GDM? Ross Lawrenson Waikato Clinical School University of Auckland Definition of GDM GDM is defined as carbohydrate intolerance
More informationThe Ever-Changing Approaches to Diabetes in Pregnancy
The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More informationA S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S
A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S P R E F A C E Dear reader, This is a synthesized handbook conceived to serve as a tool to health personnel in the screening,
More informationManaging Gestational Diabetes. Definition of GDM
Managing Gestational Diabetes Definition of GDM Gestational diabetes is defined as glucose intolerance of variable severity with onset or first recognition during pregnancy that excludes those with overt
More informationElevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance
Diabetologia (2007) 50:1033 1037 DOI 10.1007/s00125-007-0610-7 SHORT COMMUNICATION Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More informationSpecific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients
Brazilian Journal of Medical and Biological Research (1999) 32: 67-72 Insulin and proinsulin in first-degree relatives of NIDDM ISSN 1-879X 67 Specific insulin and proinsulin in normal glucose tolerant
More informationThese results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationTo see a description of the Academy Recommendation Rating Scheme (Strong, Fair, Weak, Consensus, Insufficient Evidence), click here.
Gestational Diabetes Gestational Diabetes (GDM) Guideline (2016) Gestational Diabetes GDM: Executive Summary of Recommendations (2016) Executive Summary of Recommendations Below are the major recommendations
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationEffect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome
ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology
More informationGESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016
GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar Simon Kane March 2016 Objectives History and definitions Definition and Australian data Pathophysiology and prevalence Rationale
More informationGESTATIONAL DIABETES TESTING AND TREAMENT
Boston Medical Center Maternity Care Guideline: GESTATIONAL DIABETES TESTING AND TREAMENT Accepted: August 2015 Updated: December 2018 Contributors: Aviva Lee-Parritz, MD, Sara Alexanian, MD, Kari Radoff,
More informationBreaking Convention:
Nutrition in Pregnancy: Breaking Convention: Lessons from Gestational Diabetes The Case for Complex Carbohydrates in Nutrition Therapy for Gestational Diabetes Teri L. Hernandez, PhD, RN Associate Professor
More informationEvaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus
Original Research Article DOI: 10.18231/2394-2754.2017.0014 Evaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus Reshma Shri Aravind 1,*, Latha Maheshwari
More informationADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL
ADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL *Anuradha Ghosh 1 and Sudip Kumar Saha 2 1 Department of Gynecology and Obstetrics, Sagar Dutta Medical College and
More informationComparative Study between Acarbose and Insulin in the Treatment of GDM.
Original Article DOI: 10.21276/aimdr.2018.4.2.OG5 ISSN (O):2395-2822; ISSN (P):2395-2814 Comparative Study between Acarbose and Insulin in the Treatment of GDM. Minthami Sharon 1, Niloufur Syed Bashutheen
More informationSTUDY OVERVIEW KEY TAKEAWAYS
Avocado fruit on postprandial markers of cardio-metabolic risk: A randomized controlled dose response trial in overweight and obese men and women Britt Burton-Freeman, Eunyoung Park, Indika Edirisinghe
More information2011, Editrice Kurtis
J. Endocrinol. Invest. : -, 2011 DOI: 10.2/902 The role of visfatin in the pathogenesis of gestational diabetes mellitus D.E. Gok 1, M. Yazici 1, G. Uckaya 1, S.E. Bolu 1, Y. Basaran 2, T. Ozgurtas, S.
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationNutritional Recommendations for the Diabetes Managements
In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful
More informationJournal: J. Jpn. Assoc. Dietary Fiber Res., 2000, 4 (2), (Original paper is in Japanese)
Title: Effects of Long-term Administration of Indigestible Dextrin on Visceral Fat Accumulation Authors: Yuka KISHIMOTO 1, Shigeru WAKABAYASHI 1, Katsuto TOKUNAGA 2 1 Matsutani Chemical Industry Co. Ltd.,
More informationAdditional Water Intake after Meal Reduced 2-h Postprandial Blood Glucose Level in Healthy Subjects
International Journal of Diabetes Research 2018, 7(1): 18-22 DOI: 10.5923/j.diabetes.20180701.03 Additional Water Intake after Meal Reduced 2-h Postprandial Blood Glucose Level in Healthy Subjects Vanessa
More informationGestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN
Gestational Diabetes: An Update on Testing Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN Gestational Diabetes Increased risks of: Still Birth Hydramnios Should Dystocia Prolonged Labor Preeclampsia
More informationinsulin, lipid and lipoprotein levels in twenty-five patients suffering from peripheral arterial disease. Subjects
Postgraduate Medical Journal (July 1972) 48, 409-413. The effect of fenfluramine on glucose tolerance, insulin, lipid and lipoprotein levels in patients with peripheral arterial disease B. P. BLISS M.S.,
More informationTo study the incidence of gestational diabetes mellitus and risk factors associated with GDM
International Journal of Advances in Medicine Anand M et al. Int J Adv Med. 2017 Feb;4(1):112-116 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170087
More informationAssociation of acanthosis nigricans with race and metabolic disturbances in obese women
Brazilian Journal of Medical and Biological Research (2002) 35: 59-64 Acanthosis nigricans, race and metabolic disturbances ISSN 0100-879X 59 Association of acanthosis nigricans with race and metabolic
More informationDiabetes in Pregnancy. L.Sekhavat MD
Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes
More informationKetonemia and ketonuria in gestational diabetes mellitus
HORMONES 2015, 14(4):644-650 Research paper Ketonemia and ketonuria in gestational diabetes mellitus Loukia Spanou, 1 Kalliopi Dalakleidi, 2 Konstantia Zarkogianni, 2 Anastasia Papadimitriou, 1 Konstantina
More informationManagement of Gestational Diabetes
Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following
More informationDiabetes Related Disclosures
Diabetes Related Disclosures Speakers Bureau Amylin Boehringer Ingelheim Eli Lilly Takeda Classification of Diabetes Diabetes Care January 2011 vol. 34 no. Supplement 1 S11-S61 Type 1 Diabetes Mellitus
More informationGestational diabetes mellitus (GDM) is any glucose. The Postpartum Metabolic Outcome of Women with Previous Gestational Diabetes Mellitus
Original Article 794 The Postpartum Metabolic Outcome of Women with Previous Gestational Diabetes Mellitus Chia-Hung Lin, MD; Shih-Fen Wen, BSc; Ya-Hui Wu, BSc; Yu-Yao Huang, MD, PhD; Miau-Ju Huang, MD
More informationPregestational Diabetes in Pregnancy. An Update
Pregestational Diabetes in Pregnancy An Update Disclosures D. Ware Branch, MD Nothing to disclose Questions to Be Addressed What are risks factors for adverse pregnancy outcome in pregestational diabetes?
More informationResearch: Epidemiology Overweight and obesity: a remaining problem in women treated for severe gestational diabetes
Research: Epidemiology Overweight and obesity: a remaining problem in women treated for severe gestational diabetes K. Hilden 1, U. Hanson 1,2, M. Persson 3 and H. Fadl 1 1 Department of Obstetrics and
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationPeriod of gestational diabetes mellitus diagnosis and maternal and fetal morbidity
Acta Obstet Gynecol Scand 2005: 84: 622--627 Copyright # Acta Obstet Gynecol Scand 2005 Printed in UK. All rights reserved Acta Obstetricia et Gynecologica Scandinavica ORIGINAL ARTICLE Period of gestational
More informationSubject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119
Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationduring pregnancy. any degree of impaired glucose intolerance 11/19/2012 Prevalence & Diagnosis of Gestational Diabetes
Prevalence & Diagnosis of Gestational Diabetes A.Ziaee, MD Endocrinologist Gestational diabetes mellitus (GDM); any degree of impaired glucose intolerance with onset or first recognition during pregnancy.
More informationPREGESTATIONAL DIABETES (TYPE 1 AND 2)
PREGESTATIONAL DIABETES (TYPE 1 AND 2) Women with diabetes prior to pregnancy need to evaluate and optimize their baseline to assure the healthiest pregnancy possible.[1] The overall prevalence of pregnant
More informationRisk factors of gestational diabetes mellitus among the re-birth pregnant women in Xiamen City in
46 6 2017 11 JOURNAL OF HYGIENE RESEARCH Vol. 46 No. 6 Nov. 2017 925 1000-8020 2017 06-0925-05 檾檾檾檾 DANONE INSTITUTE CHINA Young Scientists' Forum 檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾 2015 2016 1 361003 gestational
More informationMaternal Diabetes in Canada: 2004/ /15. Presented by: Dr. Chantal Nelson Canadian Perinatal Surveillance System
Maternal Diabetes in Canada: 2004/05-2014/15 Presented by: Dr. Chantal Nelson Canadian Perinatal Surveillance System Outline Introduction Methods Results Discussion 2 Introduction Both type 1 and type
More informationNORMAL GLUCOSE TOLERANCE AND GESTATIONAL DIABETES: WHAT IS IN BETWEEN?
Diabetes Care In Press, published online April 6, 2007 NORMAL GLUCOSE TOLERANCE AND GESTATIONAL DIABETES: WHAT IS IN BETWEEN? Received for publication 19 January 2007 and accepted in revised form 15 March
More informationGlucose Tolerance Testing at 34 Weeks Gestation
Date of Search: 24 Jan 2017 Sources Searched: Medline, Embase, CINAHL, TRIP Database Glucose Tolerance Testing at 34 Weeks Gestation 1) Effectiveness of screening for gestational diabetes during the late
More informationSTATE OF THE STATE: TYPE II DIABETES
STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES
More informationEffects of Starvation on Glycogen Contents of Heart, Skeletal Muscle and Liver in Several Mammals
Effects of Starvation on Glycogen Contents of Heart, Skeletal Muscle and Liver in Several Mammals Mitsuto MATSUMOTO and Tatsuo HAMADA National Institute of Animal Industry, Tsukuba Norindanchi P. O. Box
More informationFetal and Infant Growth and Glucose Tolerance in the Hertfordshire Cohort Study
Fetal and Infant Growth and Glucose Tolerance in the Hertfordshire Cohort Study A Study of and Born Between 1931 and 1939 David I.W. Phillips, Peter Goulden, Holly E. Syddall, Avan Aihie Sayer, Elaine
More informationInternational Journal of Research and Review E-ISSN: ; P-ISSN:
International Journal of Research and Review www.ijrrjournal.com E-ISSN: 2349-9788; P-ISSN: 2454-2237 Original Research Article Screening and Diagnosis of Gestational Diabetes Mellitus with Diabetes in
More informationDiabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016
Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe
More informationAssessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test
Diabetologia 2000) 43: 1507±1511 Ó Springer-Verlag 2000 Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test M. Albareda
More informationPregnancy confers a state of insulin resistance and hyperinsulinemia that. Gestational Diabetes Mellitus MANAGEMENT REVIEW
MANAGEMENT REVIEW Gestational Diabetes Mellitus Amanda Bird Hoffert Gilmartin, Serdar H. Ural, MD, John T. Repke, MD Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Penn State
More informationGestational Diabetes Mellitus (GDM) and Diabetes in Pregnancy: Diagnostic Recommendations, NSLHD
Guideline Gestational Diabetes Mellitus (GDM) and Diabetes in Pregnancy: Diagnostic Document Number GE2017_003 Publication Date 31 January 2017 Intranet location/s Summary Author Department Contact (Details)
More informationDecreased stature in gestational diabetes mellitus
Diabetologia (1998) 41: 997±1001 Ó Springer-Verlag 1998 Originals Decreased stature in gestational diabetes mellitus E. Anastasiou, M. Alevizaki, S. J. Grigorakis, G. Philippou, M. Kyprianou, A. Souvatzoglou
More informationTHE ANALYZATION OF TIME-BLOOD GLUCOSE CURVE DURING ORAL GLUCOSE TOLERANCE TEST IN PREGNANT WOMEN
Acta Transitional Medicine An International Scientific Journal ISSN: 2521-8662 Volume 1 Issue 2 pp.10-14 June 2018 THE ANALYZATION OF TIME-BLOOD GLUCOSE CURVE DURING ORAL GLUCOSE TOLERANCE TEST IN PREGNANT
More informationThe Glucose Challenge Test for Screening Gestational Diabetes in Pregnant Women with No Risk Factors
O r i g i n a l A r t i c l e Singapore Med J 2001 Vol 42(11) : 517-521 The Glucose Challenge Test for Screening Gestational Diabetes in Pregnant Women with No Risk Factors L Wong, A S A Tan Department
More informationThe association between maternal insulin resistance in mid-pregnancy and neonatal birthweight in uncomplicated pregnancies
Endocrine Journal 2014, 61 (10), 1019-1024 Original The association between maternal insulin resistance in mid-pregnancy and neonatal birthweight in uncomplicated pregnancies Hiroshi Yamashita, Ichiro
More informationLIPID AND CARBOHYDRATE METABOLIC STUDIES AFI'ER ONE YEAR OF MEGESTROL ACETATE TREATMENT*
FERTLTY AND STERLTY Copyright 1976 The American Fertility Society Vol. 27, No. 2, February 1976 Printed in U.S.A. LPD AND CARBOHYDRATE METABOLC STUDES AF'ER ONE YEAR OF MEGESTROL ACETATE TREATMENT* WLLAM
More informationReminder: NPIC/QAS CME/CEU Program
V.12.2 Special Report: Perinatal Complications associated with Gestational and Pregestational Diabetes I. Introduction Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia and
More informationSuccessful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: a case report
Kishimoto et al. Journal of Diabetes & Metabolic Disorders (2017) 16:44 DOI 10.1186/s40200-017-0327-1 CASE REPORT Successful glycemic control using a flash glucose monitoring system for a pregnant woman
More informationSCREENING FOR DIABETES IN THE FIRST TRIMESTER: WHY & HOW? Jillian Coolen, MD FRCSC DCPNS Spring Conference April 21, 2016
SCREENING FOR DIABETES IN THE FIRST TRIMESTER: WHY & HOW? Jillian Coolen, MD FRCSC DCPNS Spring Conference April 21, 2016 DISCLOSURE Site investigator for the CONCEPTT study funded by Juvenile Diabetes
More informationHypoglycemia During the 100-g Oral Glucose Tolerance Test: Incidence and Perinatal Significance
During the 100-g Oral Glucose Tolerance Test: Incidence and Perinatal Significance Amir Weissman, MD, Ido Solt, MD, Moshe Zloczower, MD, and Peter Jakobi, MD OBJECTIVE: To estimate and report the incidence
More informationCorrelation of TNF-a, TNFR1 and adiponectin levels with HOMA-IR in patients with gestational diabetes mellitus.
Biomedical Research 2017; 28 (21): 9549-9553 ISSN 0970-938X www.biomedres.info Correlation of TNF-a, TNFR1 and adiponectin levels with HOMA-IR in patients with gestational diabetes mellitus. Xiaoxia Zhou
More informationNote: for non-commercial purposes only. A collaboration between Abbott Nutrition and King s College London
Note: for non-commercial purposes only Women s Health Academic Centre A pilot study to evaluate the effects of a dietary supplement with slow digesting-low GI (SD-LGI) carbohydrates in obese pregnant women
More information2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
More informationDiabetes Care 25: , 2002
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Relationship Between Gestational Diabetes Mellitus and Low Maternal Birth Weight GIUSEPPE SEGHIERI, MD 1 ROBERTO ANICHINI,
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationIt s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children
It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children Robert Ratner, M.D., F.A.C.P. Vice President for Scientific Affairs, Medstar Research Institute
More informationSignificant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance
What s New in Gestational Diabetes? Diane Reader RD, CDE International Diabetes Center Park Nicollet Health Services Minneapolis, MN GDM Statistics What s New? Proposed Changes to Diagnostic Criteria Treatment
More informationObesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
https://doi.org/10.7180/kmj.2016.31.2.157 KMJ Original Article Obesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea Ju Won Lee, Nam Kyu Kim, Hyun Joon Park,
More informationInvestigating the diagnosis of gestational diabetes
Investigating the diagnosis of gestational diabetes A designer breakfast put to the test C MARAIS, D HALL, M CONRADIE, L V WYK STELLENBOSCH UNIVERSITY, SOUTH AFRICA DECLARATION OF INTERESTS: None Background
More informationSUMMARY. Introduction. Study design. Summary
SUMMARY Introduction The global prevalence of type 2 diabetes is increasing rapidly and nowadays affects almost 250 million people. Cardiovascular disease is the most prevalent complication of type 2 diabetes,
More informationDiabetologia 9 Springer-Verlag 1982
Diabetologia (1982) 23:240-245 Diabetologia 9 Springer-Verlag 1982 Treatment of Type 2 (Non-Insulin-Dependent) Diabetic Patients with Diet Alone J. K. Wales University Department of Medicine, General Infirmary,
More informationIntact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes
Or i g i n a l Advance Publication Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes Soushou Lee*, Daisuke Yabe**, Kyoko Nohtomi*, Michiya Takada*, Ryou
More informationParticipation in School Sports Clubs and Related Effects on Cardiovascular Risk Factors in Young Males
227 Original Article Participation in School Sports Clubs and Related Effects on Cardiovascular Risk Factors in Young Males Hiroshi KAWABE, Kazuko MURATA *, Hirotaka SHIBATA, Hiroshi HIROSE, Minako TSUJIOKA,
More informationMetabolic Disease and the Role of Nutrition
Metabolic Disease and the Role of Nutrition Robert J. Van Saun, DVM, MS, PhD Professor/Extension Veterinarian Department of Veterinary & Biomedical Sciences Pennsylvania State University Presentation Outline
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More information